APA

Kester K. E., McKinney D. A., Tornieporth N., Ockenhouse C. F., Heppner D. G., Hall T., Wellde B. T., White K., Sun P., Schwenk R., Krzych U., Delchambre M., Voss G., Dubois M., Gasser R. A., Dowler M. G., O'Brien M., Wittes J., Wirtz R., Cohen J. & Ballou W. R. (20070911). A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. : Vaccine.

Chicago

Kester Kent E, McKinney Denise A, Tornieporth Nadia, Ockenhouse Christian F, Heppner D Gray, Hall Ted, Wellde Bruce T, White Kate, Sun Peifang, Schwenk Robert, Krzych Urszula, Delchambre Martine, Voss Gerald, Dubois Marie-Claude, Gasser Robert A, Dowler Megan G, O'Brien Megan, Wittes Janet, Wirtz Robert, Cohen Joe and Ballou W Ripley. 20070911. A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. : Vaccine.

Harvard

Kester K. E., McKinney D. A., Tornieporth N., Ockenhouse C. F., Heppner D. G., Hall T., Wellde B. T., White K., Sun P., Schwenk R., Krzych U., Delchambre M., Voss G., Dubois M., Gasser R. A., Dowler M. G., O'Brien M., Wittes J., Wirtz R., Cohen J. and Ballou W. R. (20070911). A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. : Vaccine.

MLA

Kester Kent E, McKinney Denise A, Tornieporth Nadia, Ockenhouse Christian F, Heppner D Gray, Hall Ted, Wellde Bruce T, White Kate, Sun Peifang, Schwenk Robert, Krzych Urszula, Delchambre Martine, Voss Gerald, Dubois Marie-Claude, Gasser Robert A, Dowler Megan G, O'Brien Megan, Wittes Janet, Wirtz Robert, Cohen Joe and Ballou W Ripley. A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. : Vaccine. 20070911.